- Home
- ORGO vs BJRI Comparison
ORGO vs BJRI Comparison
Compare ORGO & BJRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- BJRI
- Stock Information
- Founded
- ORGO 1985
- BJRI 1978
- Country
- ORGO United States
- BJRI United States
- Employees
- ORGO N/A
- BJRI N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- BJRI Restaurants
- Sector
- ORGO Health Care
- BJRI Consumer Discretionary
- Exchange
- ORGO Nasdaq
- BJRI Nasdaq
- Market Cap
- ORGO 620.3M
- BJRI 706.6M
- IPO Year
- ORGO N/A
- BJRI 1996
- Fundamental
- Price
- ORGO $4.07
- BJRI $32.18
- Analyst Decision
- ORGO Buy
- BJRI Hold
- Analyst Count
- ORGO 3
- BJRI 6
- Target Price
- ORGO $7.33
- BJRI $40.17
- AVG Volume (30 Days)
- ORGO 765.7K
- BJRI 459.8K
- Earning Date
- ORGO 11-06-2025
- BJRI 10-30-2025
- Dividend Yield
- ORGO N/A
- BJRI N/A
- EPS Growth
- ORGO N/A
- BJRI N/A
- EPS
- ORGO N/A
- BJRI 1.17
- Revenue
- ORGO $429,531,000.00
- BJRI $1,383,611,000.00
- Revenue This Year
- ORGO $2.51
- BJRI $5.36
- Revenue Next Year
- ORGO $25.45
- BJRI $2.94
- P/E Ratio
- ORGO N/A
- BJRI $27.49
- Revenue Growth
- ORGO N/A
- BJRI 4.07
- 52 Week Low
- ORGO $2.61
- BJRI $28.92
- 52 Week High
- ORGO $6.71
- BJRI $47.02
- Technical
- Relative Strength Index (RSI)
- ORGO 40.27
- BJRI 52.91
- Support Level
- ORGO $3.84
- BJRI $29.45
- Resistance Level
- ORGO $4.40
- BJRI $31.55
- Average True Range (ATR)
- ORGO 0.22
- BJRI 0.94
- MACD
- ORGO -0.03
- BJRI 0.33
- Stochastic Oscillator
- ORGO 26.79
- BJRI 78.89
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About BJRI BJ's Restaurants Inc.
BJ's Restaurants Inc is involved in the business of owning and operating restaurants. The company operates in a single operating segment that is full-service company-owned restaurants. It has geographic presence only in the United States of America.